Comparative analysis of MitraClip/TriClip and PASCAL in transcatheter tricuspid valve repair for tricuspid regurgitation: a systematic review and meta-analysis

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Balata M.; Gbreel M.I.; Hassan M.; Becher M.U.

Journal: BMC Cardiovascular Disorders

Publisher: BioMed Central Ltd

Publication Date: 14 October 2024

Volume / Issue: Volume 24 / Issue 1

Article No.: 557

ISSN: 14712261

DOI: 10.1186/s12872-024-04201-6

Scopus: View on Scopus

PubMed: 39402473

Document Type: Article

Access: All Open Access; Gold Open Access; Green Open Access


Authors and Affiliations

Balata M., University of Erlangen-Nuremberg, Erlangen, Germany, University of Bonn, Bonn, Germany; Gbreel M.I., Faculty of Medicine, October 6 University, Giza, Egypt; Hassan M., Theodor Bilharz Research Institute, Giza, Egypt; Becher M.U., University of Bonn, Bonn, Germany, Department of Cardiology, City hospital Solingen, Solingen, Germany


Abstract

Background: The edge-to-edge transcatheter tricuspid valve repair (TTVR) has emerged as a promising technique for the treatment of tricuspid regurgitation (TR). Despite its potential, comparative data on the performance of the novel edge-to-edge devices—MitraClip, PASCAL, and TriClip—remain controversial. In this study, we aim to evaluate the safety and efficacy of these devices in treating TR. Methods: Five databases were systematically searched up to May 2023, with an updated search conducted in May 2024. Only original studies were included in the analysis and were critically evaluated using an adapted version of the Newcastle-Ottawa Scale (NOS) for observational cohort studies and the Cochrane Risk of Bias (ROB) tool for randomized controlled trials. Results: The database search yielded 2239 studies, out of which 21 studies were included in the final analysis. These studies encompassed a total of 2178 patients who underwent TTVR using either the MitraClip, TriClip, or PASCAL devices. The risk of bias across these studies ranged from moderate to high. No significant differences were found among the three devices in terms of effective regurgitant orifice area (EROA) and tricuspid regurgitant volume. However, TriClip demonstrated statistically superior efficacy in reducing vena contracta compared to both MitraClip and PASCAL (P < 0.01) [TriClip: (MD = -7.4; 95% CI: -9.24, -5.56), MitraClip: (MD = -4.04; 95% CI: -5.03, -3.05), and PASCAL: (MD = -6.56; 95% CI: -7.76, -5.35)]. The procedural success rates and incidence of single leaflet device attachment (SLDA) were similar across all devices. Furthermore, there were no significant differences in mortality, stroke rates, or major bleeding events among the three devices. Conclusion: The TriClip outperforms the MitraClip and PASCAL in reducing vena contracta width, indicating greater effectiveness for severe tricuspid regurgitation. All devices show similar safety profiles and procedural success rates. Further research is needed to confirm these results. © The Author(s) 2024.


Keywords

Meta-analysis; MitraClip; Pascal; Transcatheter tricuspid valve repair; TriClip; Tricuspid regurgitation; Aged; Aged, 80 and over; Cardiac Catheterization; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Prosthesis Design; Recovery of Function; Risk Factors; Treatment Outcome; Tricuspid Valve; Tricuspid Valve Insufficiency; all cause mortality; Article; comparative effectiveness; controlled study; data quality assessment; device comparison; disease classification; disease duration; disease severity; echocardiography; fluoroscopy; heart failure; heart left ventricle ejection fraction; hospitalization; human; meta analysis; mitral valve regurgitation; multidisciplinary team; New York Heart Association class; Newcastle-Ottawa scale; Preferred Reporting Items for Systematic Reviews and Meta-Analyses; pulmonary artery systolic pressure; risk factor; six minute walk test; systematic review; transcatheter aortic valve implantation; tricuspid annular plane systolic excursion; tricuspid valve regurgitation; tricuspid valve repair; adverse event; convalescence; devices; diagnostic imaging; heart catheterization; heart valve replacement; pathophysiology; surgery; very elderly


Citation Information

Scopus Citations: 6


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

Transcriptome analysis for Schistosoma vector snail’s Oncomelania hupensis exposed to silver nanoparticles

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region